Ji, H.-z.; Chen, L.; Ren, M.; Li, S.; Liu, T.-y.; Chen, H.-j.; Yu, H.-h.; Sun, Y.
CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway. Pharmaceuticals 2023, 16, 1210.
https://doi.org/10.3390/ph16091210
AMA Style
Ji H-z, Chen L, Ren M, Li S, Liu T-y, Chen H-j, Yu H-h, Sun Y.
CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway. Pharmaceuticals. 2023; 16(9):1210.
https://doi.org/10.3390/ph16091210
Chicago/Turabian Style
Ji, Hai-zhou, Li Chen, Mi Ren, Sang Li, Tong-yu Liu, Hong-ju Chen, Hui-hui Yu, and Yang Sun.
2023. "CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway" Pharmaceuticals 16, no. 9: 1210.
https://doi.org/10.3390/ph16091210
APA Style
Ji, H.-z., Chen, L., Ren, M., Li, S., Liu, T.-y., Chen, H.-j., Yu, H.-h., & Sun, Y.
(2023). CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway. Pharmaceuticals, 16(9), 1210.
https://doi.org/10.3390/ph16091210
